Original ResearchEribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
Under a Creative Commons license
open access
Keywords
Progression-free survival
Tolerability
Locally recurrent or metastatic breast cancer
Eribulin
Cited by (0)
- 1
Authors contributed equally.
© 2019 The Author(s). Published by Elsevier Ltd.